White Paper

Assembling The Right Team For A Successful Nonclinical Program


In drug development, nonclinical studies are essential for establishing the safety of a new potential drug product and determining a safe starting dose for human clinical trials. The key to success lies in designing and conducting the appropriate nonclinical studies to support an IND application in the most efficient and cost-effective manner.

In this paper, we offer insight into the importance of – and requirements for – nonclinical studies and provide recommendations for putting together a nonclinical program team that optimizes the likelihood of moving candidates into clinical trials.

We’ll answer questions like:

  • How can a sponsor determine the number and design of its nonclinical studies?
  • What are some key considerations for finding the right partner for a nonclinical program?
  • How can a sponsor mitigate potential challenges encountered during nonclinical studies?
access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene